Arginine Silicate Compound Promotes Blood Flow, Gains NDI Approval
Data shows Nitrosigine almost doubles maximum blood flow compared to arginine HCl and has a blood vessel relaxation effect that is almost five times greater than arginine HCl.
Nutrition 21 LLC (Purchase, NY) has launched Nitrosigine, a patented arginine silicate ingredient that the company says is superior to arginine alone at improving blood flow. FDA has accepted Nitrosigine as a new dietary ingredient (NDI).
The company cites preclinical data showing that Nitrosigine helps enhance blood flow through vasodilation by increasing nitric oxide levels. As such, the ingredient also has applications for sports nutrition and men’s health. For instance, it may enhance blood flow during and after exercise, helping with muscle growth and exercise recovery. The company says data shows Nitrosigine almost doubles maximum blood flow compared to arginine HCl and has a blood vessel relaxation effect that is almost five times greater than arginine HCl. Nitrosigine also aids silicone absorption.
“Nitrosigine provides the benefits of arginine and silicon, with additional benefits from the unique combination,” says James Komorowski, MS, CNS, the company’s vice president of scientific and regulatory affairs.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.
